Evidence-Based Practice: One Size Does Not Fit All
Author weighs evidence-based medicine vs experience and common sense when treating a patient with Alzheimer disease and cold symptoms.
Diagnosis & Disease Information
Forecasting Real-World Usage of Lecanemab for AD Treatment: An Expert Roundtable
In an expert roundtable, clinicians discuss the risks, benefits, and anticipated real-world usage of lecanemab following US FDA approval.
Mediterranean Diet Tied to Lower Risk for Dementia
Individuals with a higher adherence to a Mediterranean diet had up to 23 percent lower risk for dementia, regardless of genetic risk.
Trends in Chronic Pain and Its Management Among Nursing Home Residents With Dementia
A team of investigators evaluated numerous factors associated with the management of pain among residents of nursing homes with dementia.
How Racial and Ethnic Disparities in Alzheimer Disease Affect Diagnosis, Quality of Care
Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
FDA Approves Lecanemab for Alzheimer Disease, Despite Safety Concerns
Approval of the Alzheimer medication lecanemab comes after controversial approval in 2021 of aducanumab, which met with criticism over concerns about that drug’s effectiveness, safety, pricing
Vitamin D Deficiency Linked to Neurologic Disorders
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
Unique Alzheimer Disease Risk Factors Found in Postmenopausal Women
Cardiovascular and genetic risk factors may predict decreased brain volume in Alzheimer disease-specific brain regions in high-risk postmenopausal women.
Biomarker Discovery: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.
- Loading...
Loading...
Next post in Neurology Information Center
Loading... 
Loading...